Carl Zeiss Vision and Rodenstock have entered into a cross-license agreement for patents covering certain ophthalmic lens technologies, including Carl Zeiss Vision’s back-surface freeform progressive lens technology.
This agreement will allow Carl Zeiss Vision and Rodenstock to accelerate the delivery of advanced ophthalmic lens products and related technology to markets throughout the world.
Rodenstock
Rodenstock is Germany’s leading manufacturer of ophthalmic lenses and spectacles frames. The company, which was founded in 1877, is based in Munich and has a worldwide workforce of approximately 4,100 and is represented in more than 80 countries with sales subsidiaries and distribution partners. Rodenstock maintains production sites at 14 locations in 12 countries.
Carl Zeiss
The Carl Zeiss Group is an international leader in the fields of optics and optoelectronics. In fiscal year 2011/12 the company’s approximately 24,000 employees generated revenue of nearly 4.2 billion euros. In the markets for Industrial Solutions, Research Solutions, Medical Technology and Consumer Optics, Carl Zeiss has contributed to technological progress for more than 160 years and enhances the quality of life of many people around the globe. The Carl Zeiss Group develops and produces planetariums, eyeglass lenses, camera and cine lenses and binoculars as well as solutions for biomedical research, medical technology and the semiconductor, automotive and mechanical engineering industries. Carl Zeiss is present in over 40 countries around the globe with about 40 production facilities, over 50 sales and service locations and service locations and approximately 20 research and development sites. Carl Zeiss AG is fully owned by the Carl Zeiss Stiftung (Carl Zeiss Foundation). Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany.
Vision Care
The Vision Care business group of Carl Zeiss is the only manufacturer to combine ophthalmic expertise and solutions with an international brand. The business group develops and produces technologically excellent instruments and offerings for the entire eyeglass value chain. With around 9,500 employees, the business group is one of the world’s leading providers of eyeglass lenses and generated revenue totaling 860 million euros in fiscal year 2011/12.
